NVST
HealthcareEnvista Holdings Corporation
$22.55
+$0.86 (+3.96%)
Jan 5, 2026
Price History (1Y)
Analysis
Envista Holdings Corporation is a publicly traded company listed on the market with a ticker symbol of NVST. It operates within the healthcare sector and medical instruments & supplies industry. The company has a significant scale, with a market capitalization of $3.75 billion, revenue of $2.62 billion (TTM), and approximately 12,300 employees. The financial health of Envista Holdings Corporation indicates moderate profitability, with gross margins standing at 56.0%, operating margins at 9.7%, and profit margins at 0.6%. The company's returns on equity and assets are 0.5% and 2.7%, respectively. Its balance sheet shows $1.60 billion in debt and $1.13 billion in cash, resulting in a debt-to-equity ratio of 51.88. The valuation context for Envista Holdings Corporation reveals a P/E ratio (TTM) of 250.56 and a forward P/E of 17.73. The company has experienced revenue growth of 11.5% year-over-year, but earnings growth is not available. The dividend yield is not applicable as the payout ratio is 0.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Envista Holdings Corporation
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Visit website →Key Statistics
- Market Cap
- $3.75B
- P/E Ratio
- 250.56
- 52-Week High
- $22.68
- 52-Week Low
- $14.22
- Avg Volume
- 2.09M
- Beta
- 0.99
Company Info
- Industry
- Medical Instruments & Supplies
- Exchange
- NYQ
- Country
- United States
- Employees
- 12,300